Skip to Content

Glatiramer Acetate

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

L03AX13

CAS registry number (Chemical Abstracts Service)

0147245-92-9

Chemical Formula

(C23-H41-N5-O11)x·(C2-H4-O2)x

Therapeutic Category

Immunomodulator

Chemical Name

L-Glutamic acid polymer wit L-alanine, L-lysine and L-tyrosine, acetate (salt)

Foreign Name

  • Glatiramer acetat (German)

Generic Names

  • Glatiramer Acetate (OS: USAN, BAN, JAN)
  • 147245-92-9 (IS: CAS, old)
  • COP 1 (Teva) (IS)
  • Copolymer 1 (IS)
  • Copolymer I (synthetic peptide) (IS)
  • Glat copolymer (IS)
  • Tgal copolymer (IS)

Brand Names

  • Acetato de glatirâmero Mylan
    Mylan, Portugal
  • Aksoglatiran FS
    Nativa, Russian Federation
  • Brabio
    Alvogen, Croatia (Hrvatska); Synthon, Malta; Synthon, Netherlands
  • Clift
    Mylan, Greece; Mylan dura, Germany
  • Copaxone
    Elmor, Venezuela; Ivax, Argentina; Novamed, Colombia; Originalis, Netherlands; Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Sanofi-Aventis SA, Greece; Takeda Pharmaceutical, Japan; Teva, Australia; Teva, Bosnia & Herzegowina; Teva, Brazil; Teva, Czech Republic; Teva, Germany; Teva, Denmark; Teva, Egypt; Teva, Spain; Teva, Greece; Teva, Israel; Teva, Iceland; Teva, Lithuania; Teva, Macedonia; Teva, Norway; Teva, New Zealand; Teva, Sweden; Teva, Slovakia; Teva, Taiwan; Teva, United States; Teva Canada, Canada; Teva Eesti, Estonia; Teva Ilac, Turkey; Teva Italia, Italy; Teva Nederland, Netherlands; Teva Pharma, Belgium; Teva Pharma, Portugal; Teva Pharmaceuticals, Cyprus; Teva Pharmaceuticals, United Kingdom; Teva Pharmaceuticals, Malta; Teva Pharmaceuticals, Poland; Teva Pharmaceuticals, South Africa; Teva Romania, Romania; Teva Santé, France; Teva Serbia, Serbia; Teva-Tuteur, Paraguay
  • Copaxone 20 mg/ml
    Haemato Pharm, Austria; Teva, Austria; Teva, Hungary; Teva Pharma, Bulgaria; Teva Pharma, Switzerland
  • Copaxone 40mg/ml
    Teva, Austria; Teva, Hungary; Teva, Israel; Teva Pharma, Bulgaria
  • Copaxone Teva
    Teva, Latvia
  • Copemyl
    Mylan, Denmark; Mylan, Norway; Mylan, Sweden
  • Escadra
    Raffo, Argentina
  • Glatect
    Pharmascience, Canada
  • Glatirameracetat Alvogen
    Alvogen, Netherlands
  • Glatirameracetat Mylan
    Mylan, Netherlands
  • Glatiramer-Humanity
    BDR Pharmaceuticals, Georgia
  • Glatiramero Mylan
    Mylan, Spain
  • Glatiramyl 20mg/ml
    BGP Products, Switzerland
  • Glatopa
    Sandoz, United States
  • Glitaxon
    Medis, Tunisia
  • Perscleran 20mg/ml
    G.L. Pharma, Austria
  • Probioglat
    Probiomed, Mexico
  • Remular
    Alvogen, Croatia (Hrvatska)
  • Remurel
    Alvogen, Estonia; Alvogen, Lithuania; Alvogen, Latvia; Alvogen IPCo S.à.r.l., Iceland; Alvogen Luxembourg, Romania; Synthon, Bosnia & Herzegowina; Synthon, Bulgaria; Synthon, Bulgaria; Synthon, Slovakia
  • Sclerthon
    Synthon, Netherlands

Glossary

TermDefinition
BANBritish Approved Name
CASChemical Abstracts Service
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide